ABC | Volume 115, Nº2, Agosto 2020

Minieditorial Barroso e Souza Obesidade e Sobrepeso em Crianças e Adolescentes Arq Bras Cardiol. 2020; 115(2):172-173 1. World Health Organization.(WHO) Obesity and overweight [Internet]. Geneva: WHO; 2018 [acesso em 26 maio 2020]. Disponível em: http:// www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. 2. Ades PA,Savage PD. Obesity in coronary heart disease: an unaddressed behavioral risk factor. Prev Med. 2017 Nov;104:117-9. 3. Palmeira AC, Leal AA, Ramos NMN, Neto JAF, SimõesMOS, Medeiros CCM. Lipoprotein (a) and cardiovascular risk factors in children and adolescents. Rev Paul Pediatr. 2013;31(4):531-7. 4. Montazerifar F, Bolouri A, Mahmoudi Mozaffar M, Karajibani M. The prevalence of metabolic syndrome in coronary artery disease patients. Cardiol Res. 2016;7(6):202-8. 5. Dhungana SP, Mahato AK, Ghimire R, Shreewastav RK. Prevalence of dyslipidemia in patients with acute coronary syndrome admitted at Tertiary Care Hospital in Nepal: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2020;58(224):204-8. 6. Lee YH, Choi SH, Lee KW, Kim DJ. Apolipoprotein B/A1 ratio is associated with free androgen index and visceral adiposity and may be an indicator of metabolic syndrome in male children and adolescents. Clin Endocrinol (Oxf). 2011;74(5):579-86. 7. Aditya GP, Bari MS, Bari MA, MutalibMA, Paul GK. Association of metabolic syndrome with hyper apolipoprotein B status in young people with acute coronary syndrome. Mymensingh Med J. 2017;26(1):68-74. 8. Khalil A, Aggarwal A, Arora S, Bhattacharya J. Lipoprotein (a)--lipid profile and apolipoprotein B in children of young parents with coronary artery disease. Indian Heart J. 2011;63(5):450-3. 9. Aditya GP, Bari MA. Apolipoprotein B versus non- high density lipoprotein cholesterol as a discriminating factor for acute coronary syndrome in young people. Mymensingh Med J. 2016;25(3):458-64. 10. Bari MA, Aditya GP, Bhuiyan AS, Ahmed MU, Islam MZ, Rahman MM, et al. Measurement of apolipoprotein B may predict acute coronary syndrome in hyper-triglyceridemic young population. Mymensingh Med J. 2015;24(2):257-62. 11. Soria-FloridoMT,CastanerO,LassaleC,EstruchR,Salas-Salvadó J,Martínez- Gonzáles MA, et al. Dysfunctional high-density lipoproteins are associated with a greater incidence of acute coronary syndrome in a population at high cardiovascular risk: a nested case-control study. Circulation. 2020;141(6):444-53. 12. Aditya GP, Bari MS, Bari MA, Mutalib MA, Islam MZ, Paul GK, et al. Risk of acute coronary syndrome is better predicted by apolipoprotein B in young people than dyslipidemic parameter of conventional lipid profile. Mymensingh Med J. 2016;25(4):663-8. 13. Jesus GS, Costa PRF, Oliveira LPM, Queiroz VAO, Cunha CM, Pereira EM et al. Body Adiposity and Apolipoproteins in Children and Adolescents: A Meta-Analysis of Prospective Studies. Arq Bras Cardiol. 2020; 115(2):163-171. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 173